166 related articles for article (PubMed ID: 22046954)
1. Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.
Jensen AD; Nikoghosyan AV; Ecker S; Ellerbrock M; Debus J; Herfarth KK; Münter MW
Radiat Oncol; 2011 Nov; 6():149. PubMed ID: 22046954
[TBL] [Abstract][Full Text] [Related]
2. IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.
Jensen AD; Nikoghosyan AV; Lossner K; Herfarth KK; Debus J; Münter MW
BMC Cancer; 2012 May; 12():163. PubMed ID: 22551422
[TBL] [Abstract][Full Text] [Related]
3. COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
Jensen AD; Nikoghosyan AV; Lossner K; Haberer T; Jäkel O; Münter MW; Debus J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):37-46. PubMed ID: 26279022
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC.
Jensen AD; Nikoghosyan A; Windemuth-Kieselbach C; Debus J; Münter MW
BMC Cancer; 2010 Oct; 10():546. PubMed ID: 20937120
[TBL] [Abstract][Full Text] [Related]
5. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
[TBL] [Abstract][Full Text] [Related]
6. Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.
Jensen AD; Poulakis M; Nikoghosyan AV; Chaudhri N; Uhl M; Münter MW; Herfarth KK; Debus J
Radiother Oncol; 2015 Feb; 114(2):182-8. PubMed ID: 25640299
[TBL] [Abstract][Full Text] [Related]
7. Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
Jensen AD; Poulakis M; Vanoni V; Uhl M; Chaudhri N; Federspil PA; Freier K; Krauss J; Debus J
Radiat Oncol; 2016 Jul; 11(1):90. PubMed ID: 27386864
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas.
Schulz-Ertner D; Nikoghosyan A; Jäkel O; Haberer T; Kraft G; Scholz M; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):391-8. PubMed ID: 12738314
[TBL] [Abstract][Full Text] [Related]
9. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment.
Münter MW; Schulz-Ertner D; Hof H; Nikoghosyan A; Jensen A; Nill S; Huber P; Debus J
Radiat Oncol; 2006 Jun; 1():17. PubMed ID: 16756669
[TBL] [Abstract][Full Text] [Related]
10. High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.
Jensen AD; Poulakis M; Nikoghosyan AV; Welzel T; Uhl M; Federspil PA; Freier K; Krauss J; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Radiother Oncol; 2016 Feb; 118(2):272-80. PubMed ID: 26164774
[TBL] [Abstract][Full Text] [Related]
11. Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity.
Jensen AD; Nikoghosyan AV; Ecker S; Ellerbrock M; Debus J; Münter MW
Radiat Oncol; 2011 Apr; 6():30. PubMed ID: 21466696
[TBL] [Abstract][Full Text] [Related]
12. Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer - acute toxicity of 12C for PC.
Nikoghosyan AV; Schulz-Ertner D; Herfarth K; Didinger B; Münter MW; Jensen AD; Jäkel O; Hoess A; Haberer T; Debus J
Acta Oncol; 2011 Aug; 50(6):784-90. PubMed ID: 21767175
[TBL] [Abstract][Full Text] [Related]
13. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
14. Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts.
Rieken S; Habermehl D; Haberer T; Jaekel O; Debus J; Combs SE
Radiat Oncol; 2012 Mar; 7():41. PubMed ID: 22436135
[TBL] [Abstract][Full Text] [Related]
15. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.
Mizoe JE; Tsujii H; Kamada T; Matsuoka Y; Tsuji H; Osaka Y; Hasegawa A; Yamamoto N; Ebihara S; Konno A;
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):358-64. PubMed ID: 15380567
[TBL] [Abstract][Full Text] [Related]
16. Reirradiation of salivary gland tumors with carbon ion radiotherapy at CNAO.
Vischioni B; Dhanireddy B; Severo C; Bonora M; Ronchi S; Vitolo V; Fiore MR; D'Ippolito E; Petrucci R; Barcellini A; Ciurlia E; Iannalfi A; Hasegawa A; Molinelli S; Mirandola A; Valvo F; Orecchia R
Radiother Oncol; 2020 Apr; 145():172-177. PubMed ID: 32044529
[TBL] [Abstract][Full Text] [Related]
17. The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience.
Akbaba S; Heusel A; Mock A; Held T; Lang K; Hoerner-Rieber J; Forster T; Katayama S; Kargus S; Rieken S; Plinkert P; Herfarth K; Debus J; Adeberg S
Oral Oncol; 2019 Oct; 97():115-123. PubMed ID: 31494395
[TBL] [Abstract][Full Text] [Related]
18. Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique.
Rieken S; Habermehl D; Nikoghosyan A; Jensen A; Haberer T; Jäkel O; Münter MW; Welzel T; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e793-801. PubMed ID: 21300464
[TBL] [Abstract][Full Text] [Related]
19. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
20. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.
Akbaba S; Ahmed D; Lang K; Held T; Mattke M; Hoerner-Rieber J; Herfarth K; Rieken S; Plinkert P; Debus J; Adeberg S
Oral Oncol; 2019 Apr; 91():39-46. PubMed ID: 30926061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]